A Phase 1/2 Dose-Ranging Safety and Immunogenicity Study of mRNA-Based Candidate Pandemic Influenza Vaccines in Healthy Adults
Study Overview The research focused on evaluating mRNA-based candidate vaccines designed to address pandemic influenza. This clinical trial was pivotal […]
